Luigi Cardia
Messina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 25, 2026
Adverse Respiratory Reactions to Tyrosine Kinase Inhibitors: A Disproportionality Analysis of Spontaneous Reports from European Countries.
Journal: Life (Basel, Switzerland)
Published: December 22, 2025
Hepatotoxicity and Antimicrobial Resistance to Amoxicillin and Amoxicillin/Clavulanic Acid: Data Analysis from EudraVigilance.
Journal: Molecules (Basel, Switzerland)
Published: August 02, 2025
Transcranial magnetic resonance imaging-guided focused ultrasound for neuropathic pain treatment.
Journal: Expert review of medical devices
Published: May 07, 2025
Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 25, 2025
Moderate conscious sedation for transesophageal echocardiography guidance of percutaneous left atrial appendage closure: The MID-DEX protocol.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: February 24, 2025
Post-mastectomy pain syndrome and sleep disorders: effects of physical activity.
Journal: Frontiers in sports and active living
Published: February 19, 2025
Adverse Reactions to Ginkgo biloba Medicinal Products Released in European Countries.
Journal: Phytotherapy research : PTR
Published: January 30, 2025
Enhancing Safety in Regional Anesthesia: Guidelines from the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI).
Journal: Journal of anesthesia, analgesia and critical care
Published: January 12, 2025
Post-Intensive Care Syndrome as a Burden for Patients and Their Caregivers: A Narrative Review.
Journal: Journal of clinical medicine
Published: August 13, 2024
Adverse Reactions to the Orphan Drug Cerliponase Alfa in the Treatment of Neurolipofuscinosis Type 2 (CLN2).
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 18, 2024
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 12, 2024
Last Updated: 09/26/2026